Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ping An Good Doctor Establishes Strategic Partnership with CR Sanjiu to Jointly Promotes Pharmaceutical New Retail 2018-10-03 18:00
Hong Kong Department of Health Approves Biktarvy(R) (bictegravir, emtricitabine, tenofovir alafenamide) 2018-10-03 16:55
Veloce BioPharma Announces Positive Phase 2b Study Results for VBP-926 (Topical Povidone-Iodine in a Novel Non-Aqueous Vehicle) in Subjects with Chemotherapy-Associated Paronychia 2018-10-03 14:03
Ping An Good Doctor Forms Joint Venture with Grab to Provide One-Stop Healthcare Services in Southeast Asia 2018-10-03 10:45
People With Diabetes May Achieve Improved Glycaemic Control With Tresiba(R) Versus Glargine U100, Without an Increase in Hypoglycaemia 2018-10-02 17:59
Ryzodeg® Offers a Simpler Solution With Once-Daily Dosing and Reduced Risk of Nocturnal Hypoglycaemia vs Insulin Glargine U100 Plus Insulin Aspart 2018-10-02 17:59
Office of Generic Drugs (OGD/FDA) Awards $1M FDA Contract to CUBRC and EpiVax for Demonstration and Validation of Immunogenicity Risk Assessment Methods for Generic Peptide Drugs and Their Impurities 2018-10-02 13:00
China SXT Pharmaceuticals, Inc. Announces Effectiveness of Registration Statement on Form F-1 and Pricing the Initial Public Offering of its Ordinary Shares at $4.00 per Share 2018-09-29 05:15
NeuroAiD combined with rehabilitation has shown additive and sustained benefits on post-stroke recovery over 2 years after an initial 3-month treatment following stroke onset 2018-09-28 21:00
TransThera Biosciences Granted IND Approval from FDA to Soon Start Clinical Trials Targeting TNBC 2018-09-28 20:00
LYNCH Biologics Closes on Transaction to Purchase GEM 21S® Growth Factor Enhanced Matrix for Dental Bone Regeneration 2018-09-28 20:00
New Phase 2 Data for Somapacitan Demonstrate Its Potential as an Efficacious Once-weekly Treatment for Childhood Growth Hormone Deficiency 2018-09-28 14:40
Launch of Special Chinese Big Data Platform for Cancer Genomics Informatics to Accelerate Innovation and Development of China's Precision Diagnosis and Treatment 2018-09-28 14:04
Cellular Biomedicine Group Enters Into Strategic Licensing and Collaboration Agreement with a Global Leader in CAR-T Cell Therapy for Patients in China 2018-09-27 19:30
Luye Pharma Further Bolsters Global CNS Portfolio with Approval to Start LY03010 U.S. Clinical Trials 2018-09-27 18:41
I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Three Bispecific Antibody Programs 2018-09-26 21:27
I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Three Bispecific Antibody Programs 2018-09-26 19:24
ACT Genomics completed investment on route to become the leading DNA sequencing-based cancer solution provider in Asia 2018-09-26 12:07
Celebrating Innovators, Leaders and Business Winners in Asia's Pharma Market 2018-09-26 11:00
Ganovo Enrolled in the Basic Medical Insurance of Tianjin--Capped Reimbursement-Per-Patient Pilot Program 2018-09-26 06:30
1 336 337 338 339 340 401